FDA Approves Zevaskyn for Rare, Genetic Skin Disorder
2025-04-29
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosaContinue Reading
United States Seeing Uptick in Whooping Cough Cases
2025-04-28
Number of cases this year has reached 8,485, twice as many as this time last yearContinue Reading
HHS Announces Plans to Pay Moderna $176 Million for mRNA Flu Vaccine
2025-04-25
Government hopes to be prepared for possible bird flu pandemic or outbreak of other flu variationsContinue Reading
Novavax COVID Vaccine Moves Closer to Full FDA Approval
2025-04-25
FRIDAY, April 25, 2025 (HealthDay News) — Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update sent Novavax’s stock up more than 21% in early trading. It also helped ease fears that the decision had been delayedContinue Reading
FDA Approves Dupixent for Chronic Spontaneous Urticaria
2025-04-23
Approval granted for adults and children 12 years and older who remain symptomatic despite antihistamine treatmentContinue Reading
Teen Cannabis Use Rises in Canada After Edibles Are Legalized
2025-04-23
WEDNESDAY, April 23, 2025 (HealthDay News) — Teen cannabis use rose significantly in parts of Canada after edibles were legalized, a new study shows. The study found a 26% increase in teen cannabis use in provinces that began selling cannabis edibles and extracts in October 2019. Use of edibles aloneContinue Reading
Antibiotics Might Increase Risk of Childhood Asthma, Allergies
2025-04-23
WEDNESDAY, April 23, 2025 (HealthDay News) — Overuse of antibiotics might increase kids’ risk of developing asthma and allergies, by disrupting their gut bacteria during a crucial stage of child development, a new study says. Exposure to antibiotics prior to age 2 is associated with a 24% increased risk ofContinue Reading
Psilocybin Use Dramatically Increasing In U.S.
2025-04-23
WEDNESDAY, April 23, 2025 (HealthDay News) — Recreational use of “magic mushroom” psilocybin skyrocketed in the U.S. during the early 2020s, as states began toying with legalization of the psychedelic drug, a new study says. The number of adults 30 and older who had used psilocybin in the past yearContinue Reading
FDA and Novo Nordisk Alert Consumers to Counterfeit Ozempic
2025-04-21
Pharmaceutical company and federal agency warn consumers not to use the counterfeit medicationContinue Reading
Supreme Court Case Targets Free Preventive Care Provided By The Affordable Care Act
2025-04-21
MONDAY, April 21, 2025 (HealthDay News) — Colonoscopy for younger adults. Chest CT scans for lung cancer. Statin meds to lower cholesterol. Screening for drug addiction. More than 150 million Americans might lose no-cost access to these and other preventive care services under a case being heard Monday at theContinue Reading